Completed
A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)
NCT02964065
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Guangdong Provincial Institute of Biological Products and Materia Media Guangzhou, Guangdong, China
- Hebei Provincial Center for Disease Control and Prevention Shijiazhuang, Hebei, China
- Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China